JW Pharmaceutical Corp (001067) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.132x

Based on the latest financial reports, JW Pharmaceutical Corp (001067) has a cash flow conversion efficiency ratio of 0.132x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩46.92 Billion ≈ $31.79 Million USD) by net assets (₩354.10 Billion ≈ $239.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See JW Pharmaceutical Corp liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

JW Pharmaceutical Corp - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how JW Pharmaceutical Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.

JW Pharmaceutical Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of JW Pharmaceutical Corp ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Utilico Emerging Markets Ltd LSE:UEM	0.022x
Technoplus Ventures Ltd TA:TNPV	-0.040x
Bernard Loisea PA:ALDBL	0.144x
Power Line Engineering Public Company Limited BK:PLE	0.243x
Novavis Group SA WAR:NVG	-2.375x
Minaean SP Construction Corp V:MSP	-1.154x
Iceni Gold Ltd AU:ICL	-0.017x
Djasa Ubersakti Tbk JK:PTDU	-5.449x

Annual Cash Flow Conversion Efficiency for JW Pharmaceutical Corp (2014–2024)

The table below shows the annual cash flow conversion efficiency of JW Pharmaceutical Corp from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see 001067 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩329.49 Billion ≈ $223.29 Million	₩79.39 Billion ≈ $53.80 Million	0.241x	-26.62%
2023-12-31	₩265.44 Billion ≈ $179.89 Million	₩87.16 Billion ≈ $59.07 Million	0.328x	+30.59%
2022-12-31	₩225.76 Billion ≈ $152.99 Million	₩56.76 Billion ≈ $38.47 Million	0.251x	+161.57%
2021-12-31	₩188.54 Billion ≈ $127.77 Million	₩18.12 Billion ≈ $12.28 Million	0.096x	-68.37%
2020-12-31	₩207.47 Billion ≈ $140.60 Million	₩63.05 Billion ≈ $42.73 Million	0.304x	+25.93%
2019-12-31	₩230.09 Billion ≈ $155.93 Million	₩55.53 Billion ≈ $37.63 Million	0.241x	+20.47%
2018-12-31	₩260.11 Billion ≈ $176.27 Million	₩52.11 Billion ≈ $35.31 Million	0.200x	+62.17%
2017-12-31	₩270.78 Billion ≈ $183.50 Million	₩33.45 Billion ≈ $22.67 Million	0.124x	+406.54%
2016-12-31	₩276.31 Billion ≈ $187.25 Million	₩6.74 Billion ≈ $4.57 Million	0.024x	+231.67%
2015-12-31	₩225.41 Billion ≈ $152.75 Million	₩-4.17 Billion ≈ $-2.83 Million	-0.019x	-155.99%
2014-12-31	₩220.02 Billion ≈ $149.11 Million	₩7.28 Billion ≈ $4.93 Million	0.033x	--

About JW Pharmaceutical Corp

KO:001067 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$6.16 Million

₩9.09 Billion KRW

Market Cap Rank

#28167 Global

#2008 in Korea

Share Price

₩43950.00

Change (1 day)

-1.12%

52-Week Range

₩43950.00 - ₩65600.00

All Time High

₩131401.16